Anaesthesia during cardiopulmonary bypass (CPB) is unique and potential awareness remains a particular problem. Previously, anaesthesia for cardiac surgery mainly incorporated large doses of opiates. Volatile anaesthetic agents were often omitted or used in minimal quantities to avoid hypotension. Recently, total intravenous anaesthesia based on propofol has been used as an anaesthetic technique in cardiac surgery 1-2 . A continuous infusion of standard rate of propofol has been shown to reduce the incidence of awareness 2 . Subsequently target controlled infusion (TCI), using an internal pharmacokinetic model, has been developed to induce and maintain drug concentration. It provides the anaesthetist with the ability to target the calculated plasma concentration rather than indirect control by adjusting the infusion rate.
during hypothermic CPB. Standard clinical practice is cautious and in the attempt of avoiding awareness, anaesthetists may administer drug doses that may be larger than necessary for patients undergoing hypothermic CPB. This approach may result in a deeper state of anaesthesia, unstable haemodynamic status, prolonged recovery and increased cost.
Several years ago, bispectral index (BIS) monitoring was introduced to clinical practice. BIS decreases with increasing depth of anaesthesia and an adequate level of anaesthesia is achieved with BIS ranging from 40 to 60 10 . A good correlation between BIS and increasing sedation with propofol has been established [11] [12] . BIS-guided propofol anaesthesia has been studied widely in noncardiac surgery but there is limited study on its use during hypothermic cardiopulmonary bypass.
The aim of this study was to evaluate the impact of the use of BIS monitoring on the propofol requirements and haemodynamic stability during CPB.
MATERIALS AND METHODS
This prospective, randomised, controlled study was approved by the University of Malaya Medical Centre ethics committee. After written informed consent was obtained, we studied 20 patients (New York Heart Association class I-III) scheduled for cardiac surgery requiring CPB. Patients were randomly allocated (computer generated random numbers in closed envelopes opened when the patient arrived in the operating room) to either the BIS group (B) or the control (C) group. Exclusion criteria were previous cardiac surgery, preoperative neurological disease, ejection fraction of less than 30%, known allergy to one of the drugs used and severe renal and hepatic impairment.
All patients were premedicated with oral midazolam 0.1 mg/kg. On arrival at the holding area, Zipprep electrodes (Aspect Medical Systems) were placed on the forehead according to the taken as the baseline value. Baseline mean arterial pressure (MAP) was determined non-invasively at the same time.
In the operating theatre, two peripheral intravenous cannulas, a radial arterial cannula and an internal jugular triple lumen line were inserted under local anaesthesia. Invasive blood pressure, central venous pressure, six-lead ECG, pulse oximetry, end-tidal capnography, anaesthetic gases, nasal and rectal temperature and BIS were monitored.
After breathing 100% oxygen for three minutes through a facemask, anaesthesia was induced with intravenous fentanyl 10 μg/kg and a small dose of propofol titrated to loss of consciousness. Patients were paralysed with rocuronium 0.9 mg/kg. After tracheal intubation the lungs were ventilated with oxygen in air (FiO 2 0.5), maintaining an end-tidal CO 2 between 30 and 35 mmHg. Continuous muscle paralysis was provided by atracurium infusion and this was continued until skin closure. Anaesthesia before concentration, 0.5 to 1.5%). During CPB, hypnosis was provided by propofol using a commercial targetcontrolled infusion (TCI, Graseby 3500, Diprifusor; AstraZeneca). Additional analgesia was provided by morphine 0.2 mg/kg, administered into the pump at the onset of rewarming.
The study period commenced at the onset of CPB and continued until the end of surgery. Continuous infusion of propofol using a target concentration of 2.0 μg/ml was started in both groups once ventilation was stopped. (This target concentration is within the range of 1.5 to 3.0 μg/ml used by other investigators [3] [4] [5] [6] ). In group B, BIS-controlled adjustment of the propofol infusion was used to achieve a BIS value of 40 to 50. In group C the BIS value was not made available. The target concentration of propofol was started at 2.0 μg/ml. It was increased to 2.5 μg/ml if perfusion pressure was consistently above 90 mmHg for over up to 5 μg/kg/min. It was decreased to 1.5 μg/ml if the perfusion pressure was persistently lower than 70 mmHg despite the repeated use of phenylephrine to a maximum of 2 mg over 30 minutes. Readings of BIS and MAP were recorded at the following time intervals: 1) baseline, 2) immediately after induction, 3) at the onset of cardiopulmonary bypass, just before starting the TCI propofol infusion, 4) immediately the cardiopulmonary bypass after cross-clamping, 6) at the release of cross-clamp, 7) at the end of cardiopulmonary bypass, 8) at skin closure and 9) at the end of surgery.
All patients were managed by the same surgeon and anaesthetist. A standard cardiac surgical technique was used in all patients. Systemic heparinisation was achieved with 3 mg/kg of heparin. Roller pumps and used in the CPB circuit which was primed with 1.0 litres lactated Ringer's solution and 0.5l colloidal gelatin (Gelofusine; B Braun, Malaysia). Haematocrit concentrations were maintained between 20% and 25% and 2 was maintained throughout CPB. Myocardial protection was achieved by antegrade application of cooled St Vincent solution into the aortic root after cross-clamping. The mean perfusion pressure was maintained at 70 to 90 mmHg where possible by small boluses of phenylepherine (100 μg) and sodium nitroprusside infusion at the discretion of the perfusionist. Systemic temperature separation from CPB.
The propofol infusion was stopped in both groups when ventilation commenced and anaesthesia was then surgery. The total amount of the propofol used during the study period (not including the induction dose) and the duration of the infusion were noted. These were used to calculate the propofol administration for the patient and recorded as mg per kg of body weight per hour.
Adrenaline by infusion was administered as required for weaning from CPB. The total amount of the sodium nitroprusside and phenylephrine used were recorded. The duration of bypass and the duration of crossclamp were also recorded. Postoperative analgesia was titrated with intravenous boluses of morphine as required. Patients were extubated the next morning or thereafter according to standard protocols and based on the decision of the attending cardiac surgeon.
Using Altman's nomogram 13 it was estimated that a sample size of 10 patients per group would be able to detect a 30% difference in the dosage of propofol with 80% power and a type I error of 0.05. Analysis of data was performed with the SPSS 10.0 PC program. Data are presented as mean (SD) or range, or median (percentile). Continuous data were analysed using Student's t-test, categorical data were analysed using chi-square test. MAP and BIS score were analysed using ANOVA for repeated measures. Propofol administration, total dosage of sodium nitroprusside and phenylephrine were analysed using Mann-Whitney U tests. A P value of less than 0.05
RESULTS
Twenty patients were enrolled in the study, 10 in group B and 10 in group C. Age, weight, gender, type duration of bypass and duration of TCI anaesthesia were similar in the two groups ( Table 1) . The propofol C where standard practice (no BIS monitoring) was employed, with a median propofol dose of 6.0 mg/kg/h, whereas in group B (BIS monitoring) there was a 50% reduction of the median dose to 2.9 mg/kg/h in group B (ANOVA for repeated measurements, P=0.003).
The cumulative doses of sodium nitroprusside and phenylephrine were similar between the groups. After weaning from CPB, a similar number of patients required inotropic support (Table 1 ). MAP and BIS recordings are presented in Figures 1 and 2. The MAP values during the study period were similar between the two groups (P=0.608, ANOVA for repeated different between the two groups (P=0.026, ANOVA for repeated measurements). In group B where TCI propofol was titrated to maintain a BIS value of 40-50, the BIS values at each time interval during CPB were consistently higher when compared to group C, where the BIS values were not made available to the attending anaesthetist.
DISCUSSION
Our results demonstrate that BIS guidance for the titration of target concentration of propofol resulted in a 50% reduction of propofol administration, while the MAP values were similar between the groups.
Studies conducted on patients undergoing major Values are mean (SD). Group B=BIS guided propofol infusion; Group C=Control group. Time intervals: 1=baseline, 2=after induction, 3=at onset of bypass, 4=at cross-clamp, 5-8=every five minutes after bypass, 9-12=every five minutes before cross-clamp off, 13=off crossclamp, 14=off bypass, 15=skin closure, 16=end of procedure. P=0.608, by ANOVA for repeated measurements. surgery 14 and orthopaedic surgery 15 reported that the adequate target plasma concentration of propofol for the maintenance of anaesthesia varied from 3.5 to 4.5 μg/ml and 4 to 6 μg/ml respectively. However, the concentration needed to maintain hypnosis during hypothermic CPB is less clearcut. It is common practice to use a slightly reduced target concentration of propofol in cardiac patients and supplement it with a higher dosage of opiate. In our institution we routinely use a target concentration between 1.5 to 2.5 μg/ml during hypothermic CPB. This is comparable to the target concentrations of 1.5 to 3.0 μg/ml of propofol reported by other investigators in patients undergoing hypothermic CPB 3-6 . The differences in dosages are related to the study design and the type and dosage of opiate used to supplement anaesthesia.
During maintenance of anaesthesia, TCI has propofol than a manual infusion technique 10 . This is thought to be due to the inherent prediction error in all pharmacokinetic models. In this study the total dose of propofol used in the control group (standard practice) was 6.0 mg/kg/h which is comparable to the 6. 8 It is well known that CPB and hypothermia creates a myriad of pharmacological and physiological changes such as haemodilution, increased volume of distribution, reduced plasma binding, reduction elimination of the drug by the liver and kidney. Bailey et al showed that the pharmacokinetics of propofol in adult patients undergoing cardiac surgery with CPB is dissimilar to those reported for other adult patient populations 9 . It has been shown that during CPB the unbound concentration of propofol is increased in response to reduced plasma binding, without any alteration in the total drug concentration 7 . This propofol during CPB 8 . In addition, CPB being the hormone responses may also increase end organ sensitivity of the drug. Hypothermia itself decreased metabolic rate and may reduce the propofol administration. Schmidlin et al 17 showed that either a higher dose of propofol for normothermic patients or a lower dose for hypothermic patients is required to achieve the same target BIS value. This could be the result of increased propofol blood concentration due to decreased propofol biotransformation during hypothermia. All these factors may have explained the reduced requirement of propofol during hypothermic CPB.
standard dose of propofol used may be higher than necessary to maintain adequate hypnosis during CPB especially if TCI is used. We showed that using the usual recommended target concentration of 1.5-2.5 μg/ml, an inadvertently deep plane of anaesthesia was observed in the control group. This relative overdosage of propofol may result in lower perfusion pressure, requiring higher usage of vasopressor drugs during bypass, or an increased need of the use of inotropic drugs after the separation of CPB [18] [19] . However, despite the higher propofol administration and a much lower BIS value in the phenylephrine and inotropes. This is most probably because propofol does not affect haemodynamics during CPB, which is mostly under the control of the CPB pump, and the effects of propofol on separation of CPB are short-lived.
BIS-guided anaesthesia has been shown to reduce the amount of anaesthetic used, thus allowing shorter awakening time and earlier extubation. In this study we did not examine the extubation time, because in cardiac surgery, time to extubation depends on many different factors, such as weaning protocol, surgeons' preference, preoperative status and postoperative to extubation. Furthermore, two different types of anaesthesia were used in this study. At our institution before and after CPB and TCI of propofol was used during CPB.
The reduced administration of propofol may reduce the drug cost. However whether this translates into including the cost of the disposable BIS electrodes, will depend on the cost and protocol structure of individual clinical facilities.
The following points must be considered when assessing the clinical relevance of our study. First, hypothermic CPB reduces BIS values 17, 20 but it is in the depth of hypnosis or whether it is the effect of brain cooling and reduced electrical activity of the brain. Further study is needed concerning the effect of hypothermia on the EEG. Second, the effect of co-administered opiates on BIS during general anaesthesia is controversial. Some investigators found that opiates potentiate the hypnotic effect of propofol and thus reduce BIS when combined with propofol [21] [22] , while others have reported BIS to be insensitive to opiates 23 . The differences may be related to study design. Further investigations on the pharmacodynamic interaction between opiates and propofol on BIS values are necessary to document the effects of opiates on BIS value. In this study the temperature and the dosages of opiate are comparable opiates on BIS is unlikely to have affected the result. Third, despite the BIS value of lower than 50, we can not totally exclude the possibility of awareness. Anecdotal cases of awareness with BIS value of around 50 have been reported [24] [25] . Because of its low incidence, to detect cases of explicit awareness during CPB would require a huge study population. This study was not designed with the statistical power to detect differences for rare events such as perioperative awareness.
In conclusion, we found that BIS monitoring during hypothermic CPB enabled a reduction in the propofol administration, although the lower propofol administration did not affect the need for inotropic support or the use of vasoconstrictors during CPB. Our data support the notion that titration of propofol based on pharmacodynamic effects such as electroencephalographic suppression, is superior to administration based on pharmacokinetic modelling alone.
